Search results for "Highlights"


 
Results 81 - 90 of about 307 for "Highlights".

Drug-eluting stents may not confer advantage in diabetic patients

probably indicates a more accelerated intimal hyperplasia, greater degree of vascular inflammation and/or endothelial dysfunction, and increased plaque vulnerability in insulin-treated diabetic patients, and highlights the need for
January 2019

Patients with late-onset type 1 diabetes commonly treated as having type 2 diabetes

An analysis of patients with insulin-treated diabetes found that 38% of those with late-onset type 1 diabetes did not receive insulin at diagnosis, nearly half of whom reported a type 2 diabetes diagnosis.
May 2019

Highlights

A recent scientific statement on diabetes and heart failure summarizes the epidemiology, pathophysiology, and impact of diabetes on outcomes in heart failure; reviews pharmacological therapy and lifestyle modification; highlights the value
June 2019

Metformin associated with more long-term weight loss than lifestyle change in prediabetes patients

Other independent predictors of long-term weight loss included greater weight loss in the first year and older age, according to this follow-up analysis of the Diabetes Prevention Program.
May 2019

Poor glycemic control associated with fracture in type 1 but not type 2 diabetes

Patients with type 1 diabetes and a mean three-year HbA1c level greater than 8.0% had a higher fracture risk than those with a mean three-year HbA1c level of 7.0% or less.
February 2019

Highlights

Real-time continuous glucose monitoring (CGM), with either an insulin pump or multiple daily injections, was associated with sustained improvements in HbA1c levels compared to self-monitoring of blood glucose, according to a small randomized trial.
October 2019

SGLT2 inhibitors, GLP-1 receptor agonists compared for CV, renal outcomes

Sodium-glucose cotransporter-2 (SGLT2) inhibitors were associated with fewer hospitalizations for heart failure and slower progression of kidney disease while glucagon-like peptide-1 (GLP-1) receptor agonists were associated with lower risk of stroke
March 2019

3 actions may help reluctant patients begin insulin therapy for type 2 diabetes

Patients' perceived helpfulness of certain actions by health care professionals was linked to earlier insulin initiation and greater insulin continuation over time, a survey found.
February 2019

Highlights

Patients with diabetes and obesity who had metabolic surgery were matched in a 1:5 ratio to those who received usual care, with incidence of a major cardiovascular event (MACE) as the primary outcome.
September 2019

Cardiovascular event rates similar among newer second-line medications for type 2 diabetes

The comparison of dipeptidyl peptidase-4 inhibitors with other drug classes did find higher rates of major adverse cardiovascular events with basal insulin, sulfonylureas, and meglitinides than with the newer drugs.
January 2019

Result Page: Prev   4   5   6   7   8   9   10   11   12   13   Next